Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1623 1672 1673 1691 1693
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18225010 | METHODS FOR PRODUCING SYNTHETIC OLIGONUCLEOTIDES AND REMOVAL AGENTS FOR REMOVING IMPURITIES FROM ORGANIC WASH SOLVENTS USED IN OLIGONUCLEOTIDE SYNTHESIS | Non-Final OA | Honeywell International Inc. |
| 17986361 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | Non-Final OA | Agilent Technologies, Inc. |
| 18666922 | Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan | Non-Final OA | BOEHRINGER INGELHEIM VETMEDICA GMBH |
| 18550498 | LINE-1 INHIBITORS TO TREAT CNS AND SYSTEMIC DISEASES | Non-Final OA | TRANSPOSON THERAPEUTICS, INC. |
| 18009566 | POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS | Non-Final OA | The University of Birmingham |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy